Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia

Clinical trial NCT06217393 · COMPLETED

Trial details

NCT number: NCT06217393
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Functional Dyspepsia

Start date: 2024-02-28
Primary completion: 2025-02-28
Enrollment: 564

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.